A new study examines how cost, side effects, and other factors influence whether people stop GLP-1s, while Noom cuts staff to ...
Is compounded semaglutide effective for weight loss? Here’s the short version: Compounded semaglutide isn’t approved by the ...
The world's leading insulin manufacturer faces critical decisions as weight-loss drug demand strains production capacity.
Investors are upset at a lack of clarity over the results of Wegovy successor CagriSema after trials published in December.
Telehealth company Hims & Hers' first Super Bowl ad is provocative and effective in building awareness of its weight loss ...
Novo Nordisk is under pressure from investors for more information about its next-generation obesity drug candidate CagriSema ...
One in ten people in the UK have a needle phobia so serious it means they frequently miss out on vital treatments such as ...
It will still be too easy to buy slimming jabs online using fake details, say prescribers after new rules come into force ...
Companies such as Teladoc and Omada Health have embraced GLP-1s while dangling the prospect of lowered costs to their ...
Amgen posted a higher quarterly profit on Tuesday as product sales rose 11% and said late-stage studies of key obesity drug ...
Eli Lilly is set to report fourth-quarter earnings early Thursday, with analysts expecting rising sales and profit in the first full quarter with the company's weight-loss drugs no longer in shortage.
The company said the agency's hold was "not related to the drug,” dubbed AMG 513, and that discussions were underway to ...